Published in Lab Business Week, September 5th, 2004
"ADAMTS-1 is an extracellular matrix (ECM)-anchored metalloproteinase with proteoglycan-degrading activity as well as an angiogenesis inhibiting activity. Here, we examined the effects of ADAMTS-1 overexpression on in vivo tumor growth and tumor metastasis. Overexpression of only the C-terminal half region of ADAMTS-1, consisting of thrombospondin (TSP) type I motifs and the spacer region, suppressed Chinese hamster ovary (CHO) tumor growth in mice," researchers in Japan report.
"In addition, a significant reduction in tumor metastatic potential was observed in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.